Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on April 14, 2025
Obatala Sciences and Ainnocence Announce Partnership to Transform Drug Discovery Through AI and Human Biological Models
EIN Presswire
·
April 14, 2025
MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the FDA’s recent call for human-relevant methods for new drug development. • The partnership …
Elimu Informatics Joins AMIA as a Silver Corporate Partner to Advance Health Informatics Innovation
EIN Presswire
·
April 14, 2025
Elimu partners with AMIA as a Silver Corporate Partner, reinforcing its commitment to smarter data, better care, and health IT collaboration. EL CERRITO, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Elimu Informatics is proud to announce its …
Retina Eye UK Launches Dedicated Eye Screening and Diabetic Retinopathy Packages to Support Early Detection
EIN Presswire
·
April 14, 2025
Ms Sharon Heng has launched comprehensive eye screening and diabetic retinopathy packages aimed at improving early detection of diabetic eye disease. LONDON, LONDON, UNITED KINGDOM, April 15, 2025 /EINPresswire.com/ -- Ms Sharon Heng ,MBBS, PhD, …
Fluoropolymers Recently Diversified at Alfa Chemistry: FEP, PFA, PEEK Are Added
EIN Presswire
·
April 14, 2025
The chemical supplier Alfa Chemistry has expanded its fluoropolymer range to incorporate FEP, Perfluoroalkoxy Alkane (PFA), and Polyetheretherketone (PEEK). NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- The chemical supplier Alfa Chemistry …
InstantGMP PRO™ Ahora Disponible en Español, Expandiendo Soluciones de Cumplimiento para Fabricantes Globales
EIN Presswire
·
April 14, 2025
El software InstantGMP PRO ya está disponible en español, ayudando a los fabricantes en América Latina a optimizar los procesos para el cumplimiento de las BPM. CARY, NC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- InstantGMP™, un proveedor …
Blossom Family Medicine Partners with OpenDNA to Bring Precision Genetic Testing to Primary Care
EIN Presswire
·
April 14, 2025
ARLINGTON HEIGHTS, IL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Blossom Family Medicine is proud to announce a strategic collaboration with OpenDNA, a leader in precision medicine and AI-powered genetic analysis. This partnership brings …
The Brookbush Institute Publishes NEW Updates: 'Glossary: Stretch Shortening Cycle, Course: Power Training'
EIN Presswire
·
April 14, 2025
The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Excerpt from the course: Power (High-velocity) …
Sterling Lexicon's Redesigned Website Enhances User Experience, Showcases Talent Mobility Expertise
EIN Presswire
·
April 14, 2025
New features emphasize flexible solutions to meet changing workforce mobility priorities JACKSONVILLE, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Sterling Lexicon, a global leader in workforce mobility solutions, is proud to unveil its …
.ART ANNOUNCES 2024 AND 2025 KASIMOV ART THERAPY FELLOWSHIP RECIPIENTS
EIN Presswire
·
April 14, 2025
WASHINGTON, DC, DC, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- In celebration of the upcoming World Art Day, .ART Registry is proud to announce the 2025 recipients of the Kasimov Art Therapy Fellowship—an award established to support the next …
Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD
EIN Presswire
·
April 14, 2025
Massive Bio certifiée par la CNIL pour le traitement sécurisé des données de santé et l’appariement aux essais cliniques en France. BOCA RATON, FL, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Massive Bio obtient son attestation de certification …
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
GlobeNewswire
·
April 14, 2025
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of …
TravelingWiki Hailed: 2nd Dec. War Vet in a Wk; Actor Daniel Logan; Search Volumes At Levels of Recent Presidents
EIN Presswire
·
April 14, 2025
Resources in English, Spanish, French, German, Mandarin, Japanese, Hebrew, Arabic, Portuguese, Hindi, Twi, Vietnamese & Russian; Work with JCC, YMCAs and Beyond LOS ANGELES, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- To commemorate the …
MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025
GlobeNewswire
·
April 14, 2025
LA JOLLA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announces that their CEO, …
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
GlobeNewswire
·
April 14, 2025
- Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: …
BioSyent to Attend Planet MicroCap Showcase
GlobeNewswire
·
April 14, 2025
MISSISSAUGA, Ontario, April 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase: VEGAS 2025 investor conference in Las Vegas, Nevada from April 22nd to April …
Cue Biopharma Announces Proposed Public Offering
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Cue Biopharma to Host Business Update Call and Webcast
GlobeNewswire
·
April 14, 2025
BOSTON, April 14, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Aurora Spine Announces the Resignation of Board Director James Snow
GlobeNewswire
·
April 14, 2025
CARLSBAD, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
GlobeNewswire
·
April 14, 2025
Partnership bolsters Boehringer’s autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unmet patient need. The agreement focuses on further research and development of a novel, first-in-class bispecific compound for T cell …
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 14, 2025
WALTHAM, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it …